1. Home
  2. PODD vs NMR Comparison

PODD vs NMR Comparison

Compare PODD & NMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • NMR
  • Stock Information
  • Founded
  • PODD 2000
  • NMR 1925
  • Country
  • PODD United States
  • NMR Japan
  • Employees
  • PODD N/A
  • NMR N/A
  • Industry
  • PODD Medical/Dental Instruments
  • NMR Investment Bankers/Brokers/Service
  • Sector
  • PODD Health Care
  • NMR Finance
  • Exchange
  • PODD Nasdaq
  • NMR Nasdaq
  • Market Cap
  • PODD 21.5B
  • NMR 18.4B
  • IPO Year
  • PODD 2007
  • NMR 1961
  • Fundamental
  • Price
  • PODD $299.96
  • NMR $6.57
  • Analyst Decision
  • PODD Strong Buy
  • NMR Hold
  • Analyst Count
  • PODD 19
  • NMR 1
  • Target Price
  • PODD $320.11
  • NMR N/A
  • AVG Volume (30 Days)
  • PODD 858.4K
  • NMR 475.2K
  • Earning Date
  • PODD 08-07-2025
  • NMR 07-29-2025
  • Dividend Yield
  • PODD N/A
  • NMR 4.90%
  • EPS Growth
  • PODD 67.46
  • NMR 110.70
  • EPS
  • PODD 5.55
  • NMR 0.74
  • Revenue
  • PODD $2,198,900,000.00
  • NMR $12,637,799,087.00
  • Revenue This Year
  • PODD $24.49
  • NMR $20.15
  • Revenue Next Year
  • PODD $17.45
  • NMR $0.44
  • P/E Ratio
  • PODD $54.05
  • NMR $8.54
  • Revenue Growth
  • PODD 23.48
  • NMR 21.16
  • 52 Week Low
  • PODD $173.00
  • NMR $4.66
  • 52 Week High
  • PODD $329.33
  • NMR $6.99
  • Technical
  • Relative Strength Index (RSI)
  • PODD 53.70
  • NMR 67.83
  • Support Level
  • PODD $305.07
  • NMR $6.17
  • Resistance Level
  • PODD $316.00
  • NMR $6.64
  • Average True Range (ATR)
  • PODD 6.33
  • NMR 0.08
  • MACD
  • PODD -0.34
  • NMR 0.03
  • Stochastic Oscillator
  • PODD 69.72
  • NMR 88.71

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetics are using it worldwide.

About NMR Nomura Holdings Inc ADR

Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.

Share on Social Networks: